Processa Pharmaceuticals

-$0.04 (-0.58%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell PCSA and other stocks, options, and ETFs commission-free!

About PCSA

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its lead product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica.

CEO
David Young
Employees
14
Headquarters
Hanover, Maryland
Founded
2011

PCSA Key Statistics

Market Cap
121.24M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
57.85K
High Today
$7.10
Low Today
$6.75
Open Price
$7.00
Volume
36.25K
52 Week High
$14.24
52 Week Low
$3.40

PCSA Earnings

-$1.70
-$1.13
-$0.57
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.10 per share
Actual
Available May 13, After Hours

You May Also Like

CMO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure